以岭药业：股东大会审议通过《关于修改的议案》等多项议案

Group 1 - The core viewpoint of the article is that Yiling Pharmaceutical (002603) has passed several important resolutions during its second extraordinary general meeting of shareholders in 2025 [1] - The company approved the proposal to amend its Articles of Association [1] - The company also approved the proposal to formulate and revise certain governance systems [1] - Additionally, the company resolved to conclude fundraising investment projects and permanently supplement the remaining raised funds into working capital [1]